Industry News
CSIRO research tool enables broad searches
A research tool from CSIRO has the ability to make it easier to get information on research activities in Australia's research institutions, universities and government departments. [ + ]
Polymerat making a splash in the US
An Australian company that designs super-efficient surfaces for biochip and microplate assay systems used in high throughput proteomics screening has touched off an avalanche of US interest. [ + ]
GroPep names new CEO
Adelaide-based biotech GroPep has named former Faulding Pharmaceuticals top brass Robert Finder as its new CEO. [ + ]
Top WEHI researcher lured to UQ
The centre of gravity of Australian brain stem cell research has undergone a major shift with a change of residence by star researcher Prof Perry Bartlett and a large number of his team. [ + ]
Singapore govt awards grant to Agenix subsidiary
A Singapore government decision to award a major grant to a subsidiary of Australian listed biotech Agenix is being labelled a "great vote of confidence" by Agenix CEO Don Home. [ + ]
Stem cell Bill split but debate continues
The stem cell debate is likely to reach new levels of intensity in the wake of the vote splitting legislation permitting embryonic stem cell research from a bill outlawing human cloning. [ + ]
Researchers back beleaguered Trounson
Leading scientists came out today in support of beleaguered Stem Cell Centre of Excellence CEO Prof Alan Trounson, and urged the Federal government to pass the Stem Cell Bill, which is expected to go to a vote in the House of Representatives later today. [ + ]
Auspep aiming to ride the big waves
Australian peptide maker Auspep is looking for funds to finance its growth on the back of a market that is jagging upward. [ + ]
Novogen subsidiary to team with Yale in cancer drug trial
Marshall Edwards Inc (MIE), a subsidiary of Australian pharma Novogen, has announced an agreement with Yale University's Department of Obstetrics and Gynaecology that will allow the Yale researchers to take the company's anti-cancer drug phenoxodiol into clinical trials for ovarian cancer. [ + ]
Gene database study backs 'privacy guardians'
A new class of "privacy guardians" for genetic research databases and new laws requiring private sector researchers to conform to public sector ethical guidelines are two likely outcomes of a major Australian inquiry into the protection of genetic information. [ + ]
Autogen presents diabetes findings at Brazil conference
The discovery of a gene that links type 2 diabetes and heart disease could lead to the development of new therapeutic treatments for diabetes, according to Victorian biotech Autogen. [ + ]
GroPep sales up, tips new CEO next week
Adelaide biotech GroPep has blamed the Sydney operations it took over when it acquired Biotech Australia earlier this year for most of the $6.89m loss it sustained in the 2001-02 financial year. [ + ]
Good results boost AustCancer breast cancer program
WA-headquartered Australian Cancer Technology has accelerated its breast cancer therapeutic program after reporting good first-stage results. [ + ]
$118m for institutes in NHMRC program grants
Sixteen National Health and Medical Research Council program grants worth more than $118 million have been awarded to research teams at some of Australia's top research institutions. [ + ]
NHMRC kicks off new development funding scheme
The National Health and Medical Research Council has awarded more than $5 million to 15 researchers seeking to commercialise their discoveries, in the first round of its new development grant scheme. [ + ]